Stay updated on CDX-0159 in Eosinophilic Esophagitis Clinical Trial
Sign up to get notified when there's something new on the CDX-0159 in Eosinophilic Esophagitis Clinical Trial page.

Latest updates to the CDX-0159 in Eosinophilic Esophagitis Clinical Trial page
- Check6 days agoChange DetectedThe ClinicalTrials.gov record for the Phase 2 barzolvolimab study in adults with eosinophilic esophagitis is displayed, with details on the study design, results measures, eligibility, and participating locations.SummaryDifference67%

- Check13 days agoChange DetectedThe site footer revision changes from v3.7.2 to v3.8.0, while the study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedA sitewide NIH notice about terminology during the transition from “Artificial Intelligence” to “Super Intelligence” appears above the page, and the site revision advances from v3.7.1 to v3.7.2. The study record itself still displays a 403 error.SummaryDifference1%

- Check41 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.0 to v3.7.1. The page still displays a 403 Forbidden error rather than the study record.SummaryDifference0.2%

- Check55 days agoChange DetectedThe study record now displays a 403 Forbidden error instead of the usual study details, removing access to the trial information, locations, and related data.SummaryDifference18%

- Check62 days agoChange DetectedThe page revision tag was updated from v3.6.6 to v3.7.0, signaling a newer version of the ClinicalTrials.gov study record.SummaryDifference0.0%

Stay in the know with updates to CDX-0159 in Eosinophilic Esophagitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CDX-0159 in Eosinophilic Esophagitis Clinical Trial page.